AM-Pharma is a Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury (AKI) that could be lifesaving. The Company does not produce face masks or other medical equipment.
Developing a life-saving drug for acute kidney injury and sepsis
AM-Pharma is a leader in the development of a treatment for Acute Kidney Injury (AKI) that could be life-saving. Utilizing a concept-to-clinic approach, we have designed and developed an innovative recombinant human Alkaline Phosphatase (AP) therapeutic (recAP) from scientific research to successful Phase II clinical trials in patients with sepsis-associated AKI.
AKI is a devastating disease with high mortality rates and without approved pharmacological treatments, affecting millions of patients worldwide. Our mission is to change the treatment paradigm for patients with AKI and transform their prospects by developing and commercializing recAP, a proprietary disease-modifying biological drug.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: